2010 Fiscal Year Final Research Report
Endothelial Progenitor Cell Is Associated With Tumor Size In Human Non-Small Cell Lung Cance
| Project/Area Number |
21790765
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Respiratory organ internal medicine
|
|---|
| Research Institution | Akita University |
|---|
Principal Investigator |
SATO Kazuhiro Akita University, 医学部, 助教 (30436191)
|
|---|
| Project Period (FY) |
2009 – 2010
|
| Keywords | 血管内皮前駆細胞 / 非小細胞肺癌 / 腫瘍血管新生 / 抗腫瘍効果 |
|---|
| Research Abstract |
Rationale : Bone marrow-derived endothelial progenitor cells (EPCs) play an important role in angiogenesis and tumor growth. However, the clinical relevance of EPCs in blood vessel formation in non-small cell lung cancer (NSCLC) remains unclear. We assessed the hypothesis that EPC numbers are increased in NSCLC patients and correlate with clinicopathological factors.
Methods : EPCs labeled with CD34, CD133, and vascular endothelial growth factor receptor-2 antibodies were counted by flow cytometiry in the peripheral blood of 30 NSCLC patients. We examined age, pathological stage, histological type, Fluoro-D-glucose Positron emission tomography (FDG-PET), response to therapy, and tumor size of NSCLC patients, and investigated whether these factors correlate with EPC counts.
Results : Circulating EPC numbers before antitumor therapy were increased in NSCLC patients compared with healthy controls (p<0.05). Furthermore, in the subgroup of responders to treatment, EPC numbers were significantly lower than in non-responder patients receiving antitumor therapy (p<0.05). However, no significant associations with age, gender, histological type, pathological stage, or FDG-PET were detected.
Conclusions : Peripheral blood levels of bone marrow-derived EPCs are significantly increased in patients with NSCLC, and correlate with response to antitumor therapy.
|
